◀ Back to CSF3

CD34 — CSF3

Text-mined interactions from Literome

Kröger et al., Bone Marrow Transplant 2002 : Administering G-CSF at a dosage of 8 microg/kg twice daily leads to a higher CD34 ( + ) cell yield than a dosage of 2 x 5 microg/kg, but is associated with increased toxicity and higher cost
Cetin et al., J Clin Apher 2003 (Hematologic Neoplasms...) : In conclusion, in patients with BMI > 25 kg/m ( 2 ), once daily G-CSF compared to split dose administration induces a greater number of CD34 ( + ) stem cell mobilization, which suggests the presence of a different pharmacokinetics in obese patients
Ricciardi et al., Leukemia 2005 (Acute Disease...) : Normal CD34+ cells expressed very low levels of p-ERK, and increased p-ERK levels were found in normal G-CSF stimulated circulating CD34+ cells
Bertho et al., Stem Cells Dev 2008 : This showed that FL concentration in the blood reflected BM status before mobilization, and suggested that this parameter could be used as a predictive indicator of G-CSF induced CD34 ( + ) cell mobilization
Spahr et al., Hepatology 2008 (Fatty Liver, Alcoholic) : We studied the short-term effects of G-CSF on CD34+ stem cell mobilization, liver cell proliferation, and liver function in patients with ASH
Uchida et al., Exp Hematol 2011 : G-CSF and plerixafor mobilization resulted in CD34 ( + ) cell yields that were twofold higher than yields with G-CSF and stem cell factor
Garg et al., Gastroenterology 2012 (End Stage Liver Disease...) : After 1 month of treatment, G-CSF increased the number of CD34 ( + ) cells in the liver ( by 45 % compared with 27.5 % in group B ; P = .01 )